Linn R T, Wolf P A, Bachman D L, Knoefel J E, Cobb J L, Belanger A J, Kaplan E F, D'Agostino R B
Department of Neurology, Boston (Mass) University School of Medicine, USA.
Arch Neurol. 1995 May;52(5):485-90. doi: 10.1001/archneur.1995.00540290075020.
To evaluate the interval between the onset of detectable cognitive impairment and clinical diagnosis in individuals with probable Alzheimer's disease (AD), and to identify the pattern of the earliest changes in cognition in probable AD.
Longitudinal follow-up of a community-based cohort sample. In 1976 through 1978, a screening neuropsychological examination was administered to Framingham Study participants. These subjects were then followed up prospectively for development of probable AD for up to 13 years.
This study was conducted at a community-based center for epidemiologic research.
The surveillance sample consisted of 1045 participants in the Framingham Study aged 65 to 88 years who were free of dementia at the time of the neuropsychological screening examination.
Scores on a group of neuropsychological tests were entered into a series of age- and education-adjusted multiple regression procedures, with the presence or absence of probable AD as the outcome variable.
Considered individually, most of the screening neuropsychological measures were significantly related to later AD diagnosis. When stepwise regression procedures were employed, only measures of verbal memory and immediate auditory attention span remained significantly related to AD diagnosis. Of note, subjects later diagnosed with probable AD performed at higher levels than normal subjects on the Digit Span test at initial screening. Regression results were essentially unchanged even when the AD sample was restricted to those individuals for whom the screening examination preceded the clinical onset of dementia by 7 years or more.
These findings support previous contentions that a "preclinical phase" of detectable cognitive deficits can precede the clinical diagnosis of probable AD by many years, and they also support the hypothesis that problems with secondary verbal memory are among the first signs of AD.
评估可能患有阿尔茨海默病(AD)的个体中可检测到的认知障碍发作与临床诊断之间的间隔时间,并确定可能患有AD的个体认知最早变化的模式。
对基于社区的队列样本进行纵向随访。1976年至1978年,对弗雷明汉研究的参与者进行了筛查性神经心理学检查。然后对这些受试者进行前瞻性随访,观察可能患有AD的情况长达13年。
本研究在一个基于社区的流行病学研究中心进行。
监测样本包括1045名年龄在65至88岁之间的弗雷明汉研究参与者,他们在神经心理学筛查检查时没有痴呆症。
一组神经心理学测试的分数被纳入一系列年龄和教育程度调整的多元回归程序,以是否患有可能的AD作为结果变量。
单独考虑时,大多数筛查性神经心理学指标与后来的AD诊断显著相关。当采用逐步回归程序时,只有言语记忆和即时听觉注意力广度指标与AD诊断仍显著相关。值得注意的是,后来被诊断为可能患有AD的受试者在初始筛查时的数字广度测试中的表现高于正常受试者。即使将AD样本限制为那些筛查检查比痴呆症临床发作提前7年或更长时间的个体,回归结果基本不变。
这些发现支持了先前的观点,即可检测到的认知缺陷的“临床前期”可能在可能患有AD的临床诊断之前存在多年,并且它们还支持了继发性言语记忆问题是AD的首批迹象之一的假设。